Peter Clemmensen (@docclemme) 's Twitter Profile
Peter Clemmensen

@docclemme

ID: 2863166471

calendar_today05-11-2014 20:16:28

40 Tweet

133 Takipçi

49 Takip Edilen

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

My thoughts go to the missing in the Bahamas after the storm- to think I was recently there confronted with so much hospitality and beauty

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

The German survival rate paradox in Covid-19, simply put: when you have adequate intensive capacity you initiate treatment before it’s too late. Do limit discussion to respirators, but ask how often ECMO is used - voilà

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Terrible loss of Prof. Tony Gerslick to COVID-19. I’ll be remembering our wonderful dinner at TCT🙏. RIP friend, doctor and researcher

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Intravascular Lithotripsy for the Treatment of Calcium-Mediated Coronary In-Stent Restenoses - goo.gl/scholar/Mvj4Cc #ScholarAlerts

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

ACVC - Acute CardioVascular Care 2021 | Interlude3 (Inter6) digital-congress.escardio.org/?v=S668-interl… . really great on-line content

Raphael Twerenbold, MD (@rtwerenbold) 's Twitter Profile Photo

Today, I am leaving the UniSpitalBaselCH to follow my appointment to a professorship UKE Hamburg. Most grateful for every precious encounter, every lesson learnt and every common success with this great team CRIBasel. The story is about to continue...

Moritz Seiffert (@moritzseiffert) 's Twitter Profile Photo

First 4 cases w/ Diamondback 360 Coronary Orbital #Atherectomy System @ University Heart and Vascular Center Hamburg. Impressive results & looking forward to more. Thanks to @csi360 and OrbusNeich Medical Company Ltd. for excellent support. Christoph Waldeyer Dirk Westermann AGIK UKE Hamburg

First 4 cases w/ Diamondback 360 Coronary Orbital #Atherectomy System @ University Heart and Vascular Center Hamburg. Impressive results &amp; looking forward to more. Thanks to @csi360 and <a href="/OrbusNeich/">OrbusNeich Medical Company Ltd.</a> for excellent support. <a href="/ChristophWalde3/">Christoph Waldeyer</a>
<a href="/dirkwestermann/">Dirk Westermann</a> <a href="/AGIKinterv/">AGIK</a> <a href="/UKEHamburg/">UKE Hamburg</a>
Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Proud to contribute to this important trial Holger Thiele Most importantly: The milestone of 50% of the target 420 patients has been reached yesterday! The team by Peter Clemmensen at UHZ Hamburg included patient number 210! Thank you Peter and team!

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Today is the 45th anniversary of Grüntzig first PCI in man. Let’s celebrate this huge step in the treatment of ischemic heart disease 🎯

Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Leaving #ESCCongress2023. Great science and new guidelines. Happy to have contributed to #ECLSShock, #MULTISTARS, and #OCTOBER, clinical trials, NEJM . Guidelines will be changed!

EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

In the wake of profound sorrow and heartfelt emotion, it is with heavy hearts that we announce the sudden passing of our esteemed friend and colleague, Jean Philippe Collet, at his home. The whole obituary can be found below 👇

In the wake of profound sorrow and heartfelt emotion, it is with heavy hearts that we announce the sudden passing of our esteemed friend and colleague, Jean Philippe Collet, at his home. 

The whole obituary can be found below 👇
Peter Clemmensen (@docclemme) 's Twitter Profile Photo

Learn more about CHIP #ACC24. LEFT MAIN CORONARY INTERVENTIONS IN HIGH-RISK SURGICAL PATIENTS: TEMPORAL TRENDS AND IN-HOSPITAL... - goo.gl/scholar/2PVwYL #ScholarAlerts